You are here

Zentalis

Zentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths

Fierce Biotech

Tue, 06/18/24 - 11:30 am

clinical trials

platinum-resistant ovarian cancer

5 of the best paid biopharma CEOs

PharmaVoice

Mon, 11/13/23 - 10:10 am

executive compensation

Sarepta Therapeutics

Pfizer-partnered Zentalis woos new CEO, cobbles together $200M

Endpoints

Mon, 05/16/22 - 07:37 pm

AACR 2022 – A weekend of updates yields few winners

EP Vantage

Tue, 04/12/22 - 10:34 am

Bicycle Therapeutics

Rubius Therapeutics

C4 Therapeutics

Zentalis keeps the heat on AstraZeneca with early WEE1 data showing a group of 'exceptional' responders

Endpoints

Sun, 04/11/21 - 11:49 pm

Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture

Endpoints

Wed, 05/20/20 - 10:48 am

Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO

Bloomberg

Fri, 04/3/20 - 11:20 am